Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$420M |
| 2 |
Zoom
ZM
|
+$370M |
| 3 |
Uber
UBER
|
+$267M |
| 4 |
Intel
INTC
|
+$247M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$421M |
| 2 |
AbbVie
ABBV
|
+$266M |
| 3 |
Amgen
AMGN
|
+$212M |
| 4 |
PPLI
People Inc
PPLI
|
+$207M |
| 5 |
Eli Lilly
LLY
|
+$100M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.49% |
| 2 | Healthcare | 14.08% |
| 3 | Financials | 12.39% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Communication Services | 9.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Rockwell Medical
RMTI
$28.2M
| $994K | ﹤0.01% |
8,448
+292
| +4% | +$50.5K |
|
|
FSFG
3202
DELISTED
First Savings Financial Group
FSFG
| $993K | ﹤0.01% |
54,843
+561
| +1% | +$8.38K |
|
3203
Shinhan Financial Group
SHG
$35.6B
| $993K | ﹤0.01% |
43,232
+2,739
| +7% | +$69K |
|
3204
OP Bancorp
OPBK
$233M
| $992K | ﹤0.01% |
173,579
+1,091
| +0.6% | +$6.85K |
|
|
FNHC
3205
DELISTED
FedNat Holding Company Common Stock
FNHC
| $992K | ﹤0.01% |
157,045
+2,966
| +2% | +$26.9K |
|
|
DOYU
3206
DouYu International Holdings
DOYU
$142M
| $989K | ﹤0.01% |
7,490
+2,782
| +59% | +$399K |
|
3207
KB Financial Group
KB
$43.5B
| $983K | ﹤0.01% |
30,635
+11,938
| +64% | +$370K |
|
|
MFNC
3208
DELISTED
Mackinac Financial Corporation
MFNC
| $976K | ﹤0.01% |
101,175
+2,610
| +3% | +$25.1K |
|
|
LKFT
3209
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
| $975K | ﹤0.01% |
6,871
+368
| +6% | +$61.4K |
|
3210
Ultralife
ULBI
$106M
| $975K | ﹤0.01% |
165,344
+546
| +0.3% | +$3.59K |
|
3211
Willis Lease Finance
WLFC
$1.29B
| $974K | ﹤0.01% |
158,508
+2,958
| +2% | +$21.4K |
|
|
HZN
3212
DELISTED
Horizon Global Corporation
HZN
| $973K | ﹤0.01% |
169,229
-6,121
| -3% | -$29.7K |
|
|
LMPX
3213
DELISTED
LMP Automotive Holdings, Inc. Common Stock
LMPX
| $969K | ﹤0.01% |
+35,738
| New | +$461K |
|
3214
Actinium Pharmaceuticals
ATNM
$25M
| $967K | ﹤0.01% |
99,806
+12,693
| +15% | +$140K |
|
|
AIFU
3215
AIFU Inc
AIFU
$221M
| $967K | ﹤0.01% |
144
+26
| +22% | +$212K |
|
3216
Abeona Therapeutics
ABEO
$413M
| $965K | ﹤0.01% |
37,848
-265
| -0.7% | -$16.7K |
|
|
CMBM
3217
DELISTED
Cambium Networks
CMBM
| $964K | ﹤0.01% |
57,185
+18,537
| +48% | +$243K |
|
3218
Lineage Cell Therapeutics
LCTX
$274M
| $956K | ﹤0.01% |
1,021,544
| – | – |
|
3219
Electromed
ELMD
$349M
| $955K | ﹤0.01% |
91,778
+7,371
| +9% | +$106K |
|
3220
Culp Inc
CULP
$44.1M
| $951K | ﹤0.01% |
76,601
| – | – |
|
3221
POSCO
PKX
$17.5B
| $949K | ﹤0.01% |
+22,691
| New | +$917K |
|
3222
Research Frontiers
REFR
$17M
| $949K | ﹤0.01% |
351,738
+2,140
| +0.6% | +$6.2K |
|
3223
Rush Enterprises Class B
RUSHB
$6.14B
| $948K | ﹤0.01% |
48,186
+2,293
| +5% | +$41.8K |
|
|
MBII
3224
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $945K | ﹤0.01% |
775,106
+2,276
| +0.3% | +$2.77K |
|
3225
Fennec Pharmaceuticals
FENC
$402M
| $944K | ﹤0.01% |
155,787
+5,587
| +4% | +$39.4K |
|
Similar funds
Geode Capital Management's Q3 2020 Portfolio in Review
As of Q3 2020, Geode Capital Management held 4,244 positions worth $510B, up 9.2% from $467B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2020 filing shows 144 new, 2,112 increased, 1,496 reduced and 90 closed positions. Its largest new stake was Snowflake: 195,170 shares worth $48.9M. The largest sale was Apple, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q3 2020 buy was Snowflake: 195,170 shares worth $48.9M.
- Geode Capital Management added most to Amazon in Q3 2020, an estimated $420M increase.
- Geode Capital Management's biggest Q3 2020 reduction was Apple, cutting an estimated $421M.
- Geode Capital Management fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $84.5M.
- Geode Capital Management's ten largest holdings make up 23% of its $510B portfolio in Q3 2020.
- Geode Capital Management opened 144 new positions and closed 90 in Q3 2020.
- Geode Capital Management's portfolio value rose 9.2% quarter-over-quarter to $510B.
Based on Geode Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.